Ra Medical Systems, Inc.
RMED · AMEX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 6.6% | 48.3% | 53.8% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 92% | 93.4% | 92.3% | 93.5% |
| EBITDA | -$0 | -$0 | -$0 | $0 |
| % Margin | -753.5% | -2,203.8% | -2,492.3% | 53,360.8% |
| Net Income | -$0 | -$0 | -$0 | $0 |
| % Margin | -996% | -2,409.9% | -2,828.7% | 52,582.8% |
| EPS Diluted | -1.7 | -0.38 | -0.36 | 18.54 |
| % Growth | -347.4% | -5.6% | -101.9% | – |
| Operating Cash Flow | -$0 | $0 | -$0 | $0 |
| Capital Expenditures | -$0 | $0 | -$0 | -$0 |
| Free Cash Flow | -$0 | $0 | -$0 | $0 |